A digit symbol coding task as a screening instrument for cognitive impairment in first-episode psychosis

Archives of Clinical Neuropsychology

Volumn 26, Issue 1, 2011, Pages 48-58

  González Blanch, César ^a   Pérez Iglesias, Rocío ^a   Rodríguez Sánchez, José Manuel ^a   Pardo García, Gema ^a   Martínez García, Obdulia ^a   Vázquez Barquero, José Luis ^a   Crespo Facorro, Benedicto ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

coding task; cognitive screening; neuropsychological assessment; schizophrenia

Indexed keywords

EID: 79251491083     PISSN: 08876177     EISSN: 18735843     Source Type: Journal    
DOI: 10.1093/arclin/acq086     Document Type: Article

References (54)

1. Andreasen, N.C. (1981). Scale for the Assessment of Negative Symptoms (SANS). University of Iowa, Iowa City, IA.
2. Andreasen, N.C. (1983). Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa, Iowa City, IA.
3. Andreasen, N. C., Flaum, M., & Arndt, S. (1992). The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry, 49 (8), 615-623.
4. Andreasen, N. C., Paradiso, S., & O'Leary, D. S. (1998). "Cognitive dysmetria" as an integrative theory of schizophrenia: A dysfunction in cortical- subcortical-cerebellar circuitry? Schizophrenia Bulletin, 24 (2), 203-218.
5. Badcock, J. C., Dragovic, M., Waters, F. A., & Jablensky, A. (2005). Dimensions of intelligence in schizophrenia: Evidence from patients with preserved, deteriorated and compromised intellect. Journal of Psychiatric Research, 39 (1), 11-19.
6. Bromley, E. (2007). Clinicians' concepts of the cognitive deficits of schizophrenia. Schizophrenia Bulletin, 33 (3), 648-651.
7. Buchanan, R. W., Davis, M., Goff, D., Green, M. F., Keefe, R. S., Leon, A. C., et al. (2005). A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophrenia Bulletin, 31 (1), 5-19.
8. Carey, C. L., Woods, S. P., Gonzalez, R., Conover, E., Marcotte, T. D., Grant, I., et al. (2004). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. Journal of Clinical and Experimental Neuropsychology, 26 (3), 307-319.
9. Cegalis, J., & Bowlin, J. (1991). Vigil: Software for the Assessment of Attention. Nashua, NH: Forthought.
10. Crespo-Facorro, B., Perez-Iglesias, R., Ramirez-Bonilla, M., Martinez-Garcia, O., Llorca, J., & Luis Vazquez-Barquero, J. (2006). A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. Journal of Clinical Psychiatry, 67 (10), 1511-1521.
11. Dickinson, D. (2008). Digit symbol coding and general cognitive ability in schizophrenia:Worth another look. British Journal of Psychiatry, 193 (5), 354-356.
12. Dickinson, D., Iannone, V. N., Wilk, C. M., & Gold, J. M. (2004). General and specific cognitive deficits in schizophrenia. Biological Psychiatry, 55 (8), 826-833.
13. Dickinson, D., Ramsey, M. E., & Gold, J. M. (2007). Overlooking the obvious: A meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry, 64 (5), 532-542.
14. Duff, K., & Grabowski, T. J. (2008). Normal Aging, Mild Cognitive Impairment, and Dementia. In A. McNeill-Horton, & D. Wedding (Eds.), The neuropsychology handbook (pp. 571-602). New York: Springer Publishing.
15. First, M.B., Spitzer, R.L., Gibbon, M., & Williams, J.B.W. (1995). Structured Clinical Interview for DSM-IV Axis I Disorders, Biometrics Research Department. New York: State Psychiatric Institute.
16. Gold, J. M. (2004). Cognitive deficits as treatment targets in schizophrenia. Schizophrenia Research, 72 (1), 21-28.
17. González-Blanch, C., Álvarez-Jiménez, M., Rodríguez-Sánchez, J. M., Pérez-Iglesias, R., Vázquez-Barquero, J. L., & Crespo-Facorro, B. (2006). Cognitive functioning in the early course of first-episode schizophrenia spectrum disorders: Timing and patterns. European Archives of Psychiatry and Clinical Neuroscience, 256 (6), 364-371.
18. González-Blanch, C., Crespo-Facorro, B., Álvarez- Jiménez, M., Rodríguez-Sánchez, J. M., Pérez- Iglesias, R., Pelayo-Terán, J. M., et al. (2008). Lack of association between clinical and cognitive change in first-episode psychosis: The first 6 weeks of treatment. Canadian Journal of Psychiatry, 53 (12), 839-847.
19. González-Blanch, C., Crespo-Facorro, B., Álvarez- Jiménez, M., Rodríguez-Sánchez, J. M., Pelayo-Terán, J. M., Pérez-Iglesias, R., et al. (2007). Cognitive dimensions in first-episode schizophrenia spectrum disorders. Journal of Psychiatric Research, 41 (11), 968-977.
20. Gonzalez-Blanch, C., Perez-Iglesias, R., Pardo-Garcia, G., Rodriguez-Sanchez, J. M., Martinez-Garcia, O., Vazquez-Barquero, J. L., et al. (2010). Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia. Psychological Medicine, 40 (6), 935-944.
21. Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000). Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the "right stuff"? Schizophrenia Bulletin, 26 (1), 119-136.
22. Groth-Marnat, G. (2003). Handbook of psychological assessment (4th ed.). New York: John Wiley & Sons.
23. Hanley, J. A., & McNeil, B. J. (1983). A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology, 148 (3), 839-843.
24. Harvey, P. D., Serper, M. R., White, L., Parrella, M. J., McGurk, S. R., Moriarty, P. J., et al. (2001). The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia. Comprehensive Psychiatry, 42 (4), 306-313.
25. Heinrichs, R.W., & Zakzanis, K. K. (1998). Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology, 12 (3), 426-445.
26. Hofer, A., Niedermayer, B., Kemmler, G., Rettenbacher, M. A., Trebo, E., Widschwendter, C. G., et al. (2007). Cognitive impairment in schizophrenia: Clinical ratings are not a suitable alternative to neuropsychological testing. Schizophrenia Research, 92 (1-3), 126-131.
27. Hogarty, G. E., Greenwald, D. P., & Eack, S. M. (2006). Durability and mechanism of effects of cognitive enhancement therapy. Psychiatric Services, 57 (12), 1751-1757.
28. Hong, K. S., Kim, J. G., Koh, H. J., Koo, M. S., Kim, J. H., Lee, D., et al. (2002). Effects of risperidone on information processing and attention in first-episode schizophrenia. Schizophrenia Research, 53 (1-2), 7-16.
29. Hosmer, C., & Lemeshow, S. (2000). Applied logistic regression (2nd ed.). New York: Wiley.
30. Hurford, I. M., Marder, S. R., Keefe, R. S., Reise, S. P., & Bilder, R. M. (in press). A Brief Cognitive Assessment Tool for Schizophrenia: Construction of a Tool for Clinicians. Schizophrenia Bulletin.
31. Hyman, S. E., & Fenton, W. S. (2003). Medicine. What are the right targets for psychopharmacology? Science, 299 (5605), 350-351.
32. Keefe, R. S., Bilder, R. M., Harvey, P. D., Davis, S. M., Palmer, B. W., Gold, J. M., et al. (2006). Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology, 31 (9), 2033-2046.
33. Keefe, R. S., Goldberg, T. E., Harvey, P. D., Gold, J. M., Poe, M. P., & Coughenour, L. (2004). The Brief Assessment of Cognition in Schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophrenia Research, 68 (2-3), 283-297.
34. Keefe, R. S., Poe, M., Walker, T. M., Kang, J. W., & Harvey, P. D. (2006). The Schizophrenia Cognition Rating Scale: An interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. American Journal of Psychiatry, 163 (3), 426-432. (Pubitemid 44469384)
35. King, J. E. (2003). Running a best-subsets logistic regression: An alternative to stepwise methods. Educational and Psychological Measurement, 63 (3), 392-403.
36. Lezak, M. D., Howieson, D. B., & Loring, W. (2004). Neuropsychological assessment (4th ed.). New York: Oxford University Press.
37. Mañá, S., Ivorra, J., & Girón, M. (1998). Adaptación y fiabilidad de la entrevista para la evaluación de la discapacidad social en pacientes psiquiátricos (OMS). Revista de Psiquiatría de la Facultad de Medicina de Barcelona, 25 (2), 43-48.
38. Mesholam-Gately, R. I., Giuliano, A. J., Goff, K. P., Faraone, S. V., & Seidman, L. J. (2009). Neurocognition in first-episode schizophrenia: A meta-analytic review. Neuropsychology, 23 (3), 315-336.
39. Mohamed, S., Paulsen, J. S., O'Leary, D., Arndt, S., & Andreasen, N. (1999). Generalized cognitive deficits in schizophrenia: A study of first-episode patients. Archives of General Psychiatry, 56 (8), 749-754. (Pubitemid 29357737)
40. Niendam, T. A., Bearden, C. E., Rosso, I. M., Sanchez, L. E., Hadley, T., Nuechterlein, K. H., et al. (2003). A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. American Journal of Psychiatry, 160 (11), 2060-2062.
41. Overall, J. E., & Gorham, D. R. (1962). The Brief Psychiatric Rating Scale. Psychological Report, 10, 799-812.
42. Peña-Casanova, J., Gramunt, N., & Gich, J. (2004). Test neuropsicológicos. Fundamentos para una neuropsicología clínica basada en evidencias. Barcelona: Masson.
43. Purdon, S. E. (2005). The Screen for Cognitive Impairment in Psychiatry (SCIP): Instructions and three alternate forms. Edmonton: PNL.
44. Reichenberg, A., Harvey, P. D., Bowie, C. R., Mojtabai, R., Rabinowitz, J., Heaton, R. K., et al. (2009). Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophrenia Bulletin, 35 (5), 1022-1029.
45. Rey, A. (1987). Test de Copia de la Figura Compleja [Rey Complex Figure Test]. Madrid: TEA Ediciones.
46. Rodríguez-Sánchez, J. M., Crespo-Facorro, B., González-Blanch, C., Pérez-Iglesias, R., & Vázquez-Barquero, J. L. (2007). Cognitive dysfunction in firstepisode psychosis: The processing speed hypothesis. The British Journal of Psychiatry: Supplement, 51, s107-s110.
47. Rodríguez-Sánchez, J. M., Pérez-Iglesias, R., González-Blanch, C., Pelayo-Terán, J. M., Mata, I., Martínez, O., et al. (2008). 1-year follow-up study of cognitive function in first-episode non-affective psychosis. Schizophrenia Research, 104 (1-3), 165-174.
48. Schretlen, D., Bobholz, J., & Brandt, J. (1996). Development and psychometric properties of the Brief Test of Attention. The Clinical Neuropsychologist, 10, 80-89.
49. Spreen, O., & Strauss, E. (1998). A Compendium of neuropsychological test: Administration, norms, and commentary (2nd ed.). New York: Oxford University Press.
50. Velligan, D. I., DiCocco, M., Bow-Thomas, C. C., Cadle, C., Glahn, D. C., Miller, A. L., et al. (2004). A brief cognitive assessment for use with schizophrenia patients in community clinics. Schizophrenia Research, 71 (2-3), 273-283.
51. Ventura, J., Cienfuegos, A., Boxer, O., & Bilder, R. (2008). Clinical global impression of cognition in schizophrenia (CGI-CogS): Reliability and validity of a co-primary measure of cognition. Schizophrenia Research, 106 (1), 59-69.
52. Wechsler, D. (1999). WAIS-III. Escala de inteligencia de Wechsler para adultos-III [Wechsler Adult Intelligence Scale-III]. Madrid: TEA Ediciones.
53. Wykes, T., Reeder, C., Corner, J., Williams, C., & Everitt, B. (1999). The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophrenia Bulletin, 25 (2), 291-307.
54. Youden, W. J. (1950). Index for rating diagnostic tests. Cancer, 3 (1), 32-35.